This study with the aim of the definition of The effect of supplementation with iron alone and combined with the docosa hexaenoic acid and changes in serum lipid profile on risk of Coronary- heart disease via measuring paraoxonase 1, hs-CRP and the ApoB / ApoA1 ratio in women with iron deficiency anemia carried in a Randomized placebo-controlled double-blind Clinical trial In a period of 21 months in women15-45 years of age with iron deficiency anemia. Among of patients were willing to cooperate, Background, anthropometric, biochemical and dietary intake and physical activity will be assessed.to And if having Serum ferritin less than 12 ϻ g / l and serum iron of 60 mcg/100ml and don’t have diabetes, thalassemia, history of peptic ulcer disease or malabsorption and lack of blood transfusions in the past 2 months, 80 patients are enrolled . Of the two groups receiving supplemental DHA + ferrous sulfate or placebo + ferrous sulfate into each day, 1 capsule of 500 mg DHA or placebo, with a tablet inserted sulfate contains 50 mg of elemental iron for 12 weeks taking . From 24-hour dietary recalls at baseline and end of study to be taken daily intake of calories, carbohydrates, fat, protein, fiber and antioxidants, especially vitamins A, C and E, beta carotene, zinc, selenium, iron, copper, Sodium, potassium and dietary fat type is specified. In the study cardiovascular disease is evaluated by measuring paraoxonase 1, hs-CRP and the ApoB / ApoA1 and compared in two groups.